Oxford Industries (OXM) Q1 earnings: Taking a look at key metrics versus estimates

Oxford Industries reported $392.86 million in revenue for the quarter ended April 2025, representing a year-over-year decline of 1.3%. EPS of $1.82 for the same period compares to $2.66 a year ago.

The reported revenue represents a surprise of +1.98% over the Zacks Consensus Estimate of $385.23 million. With the consensus EPS estimate being $1.82, the company has not delivered EPS surprise.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Oxford Industries performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Net sales- Emerging brands: $34.20 million compared to the $33.70 million average estimate based on two analysts. The reported number represents a change of +3.6% year over year.
• Net sales- Lilly Pulitzer: $99 million versus the two-analyst average estimate of $91.10 million. The reported number represents a year-over-year change of +12%.
• Net sales- Tommy Bahama: $216.20 million versus the two-analyst average estimate of $214.30 million. The reported number represents a year-over-year change of -4.2%.
• Net sales- Johnny Was: $43.50 million versus $46.10 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -15% change.

Shares of Oxford Industries have returned -6.4% over the past month versus the Zacks S&P 500 composite's +6.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Download 7 Best Stocks for the Next 30 Days. Click to get this free report